Study on the interaction between doxorubicin and Deoxyribonucleic acid with the use of methylene blue as a probe (original) (raw)

New trends in photobiologyPhotochemical interactions of methylene blue and analogues with DNA and other biological substrates

Eimer Tuite

Journal of Photochemistry and Photobiology B: Biology, 1993

View PDFchevron_right

DNA interactions of 2-pyrrolinodoxorubicin, a distinctively more potent daunosamine-modified analogue of doxorubicin

Barbora Liskova, Jaroslav Malina

Biochemical Pharmacology, 2011

View PDFchevron_right

146 The binding mechanisms of methylene blue with DNA

Ara Antonyan

Journal of Biomolecular Structure and Dynamics, 2015

View PDFchevron_right

Single-molecule brightness analysis for the determination of anticancer drug interactions with DNA

Robert Holyst

The Analyst, 2020

View PDFchevron_right

Drug–DNA interactions and their study by UV–Visible, fluorescence spectroscopies and cyclic voltametry

Amin Badshah

Journal of Photochemistry and Photobiology B Biology, 2013

View PDFchevron_right

Study on the interaction between morin-bi(III) complex and DNA with the use of methylene blue dye as a fluorophor probe

Ali A. Ensafi

Journal of the Brazilian Chemical Society, 2009

View PDFchevron_right

Kinetics of drug-DNA interaction

Laurence Wakelin

Journal of Molecular Biology, 1980

View PDFchevron_right

From non-covalent binding to irreversible DNA lesions: nile blue and nile red as photosensitizing agents

Marco Marazzi

Scientific Reports, 2016

View PDFchevron_right

Interaction between an 8-methoxypyrimido[4′,5′:4,5] thieno (2,3-b)quinoline-4(3H)one antitumour drug and deoxyribonucleic acid

Sanjeev R Inamdar

Journal of Chemical Sciences, 2002

View PDFchevron_right

Preferential binding of anticancer drugs to triplex DNA compared to duplex DNA: a spectroscopic and calorimetric study

Neelam Lohani

RSC Adv., 2016

View PDFchevron_right

Relationships between DNA-binding kinetics and biological activity for the 9-aminoacridine-4-carboxamide class of antitumor agents

Gordon Rewcastle

Journal of medicinal …, 1987

View PDFchevron_right

Effect of troxerutin on 2-aminoanthracene and DNA interaction and its anti-mutagenic property

Chinnasamy Thirunavukkarasu

Biomedicine & Pharmacotherapy, 2017

View PDFchevron_right

Mechanism of DNA-drug interactions

Arvind M. Kayastha

Applied Biochemistry and Biotechnology, 1994

View PDFchevron_right

The Power and Potential of Doxorubicin-DNA Adducts

Abraham Nudelman

IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), 2005

View PDFchevron_right

In vitro studies on DNA-photosensitization by different drug stereoisomers

Virginie Lhiaubet-vallet

Toxicology in Vitro, 2003

View PDFchevron_right

Spectroscopic and In Silico Evaluation of Interaction of DNA with Six Anthraquinone Derivatives

pritha ghosh, Akella Sivaramakrishna

Applied Biochemistry and Biotechnology, 2013

View PDFchevron_right

GEOMETRICAL AND CONFORMATIONAL STERIC AFFINITY INTERACTION STUDIES OF ANTICANCER DRUGS WITH HEXANUCLEOTIDE SEQUENCES OF DNA BY FLUORESCENCE AND ABSORPTION SPECTROPHOTOMETRY

sulabh kharbanda, Sky Institute

View PDFchevron_right

Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: Structural features and biological implications

Daniel Agudelo

International Journal of Biological Macromolecules, 2014

View PDFchevron_right

Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro

Karsten Wassermann

Cancer research, 1986

View PDFchevron_right

Spectroscopic and molecular modeling study on the interaction of ctDNA with 3′-deoxy-3′-azido doxorubicin

Asma Verdian, ahmad asoodeh

Journal of Luminescence, 2013

View PDFchevron_right

Structural changes of DNA induced by mono- and binuclear cancer drugs

Sabyasachi Sarkar

Journal of Structural Biology, 2005

View PDFchevron_right

Supplementary Figures S1- S22. from Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs

Igor Koman

2023

View PDFchevron_right

Spectroscopic Studies of the Binding Interactions of Phenothiazininum Dyes (Thionine Acetate, Azure A and Azure B) with Calf-thymus DNA

Mahima Kaushik

Journal of Drug Metabolism & Toxicology, 2016

View PDFchevron_right

Nucleic acid binding drugs—XIV

B. Baguley

Biochemical Pharmacology, 1986

View PDFchevron_right

New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA

Henryk Kozlowski, Milena Salerno

Chemico-Biological Interactions, 2003

View PDFchevron_right

Investigations of drug–DNA interactions using molecular docking, cyclic voltammetry and UV–Vis spectroscopy

Fouzia Aslam

View PDFchevron_right

DNA damage and sequence specificity of DNA binding of the new anti-cancer agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis maleate)

kurt kohn

British journal of cancer, 1990

View PDFchevron_right